An intravenous angiogenesis inhibitor for second-line treatment of advanced gastric or gastroesophageal junction cancer.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An intravenous angiogenesis inhibitor for second-line treatment of advanced gastric or gastroesophageal junction cancer.
If you have a Hayes login, click here to view the full report on the Knowledge Center.